Drug Fever Due to Favipiravir Administration for the Treatment of a COVID-19 Patient

A 55-year-old Japanese man was hospitalized with the novel coronavirus disease 2019 (COVID-19). On the 14th day after the start of favipiravir administration, the patient developed a fever with a temperature of 38.1℃. His pulse rate also became elevated to 128 bpm, so relative bradycardia was not su...

Descripción completa

Detalles Bibliográficos
Autores principales: Tawara, Junsuke, Uehara, Takanori, Sakao, Seiichiro, Igari, Hidetoshi, Taniguchi, Toshibumi, Kasai, Hajime, Takayanagi, Shin, Yahaba, Misuzu, Shimada, Ryo, Ikusaka, Masatomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079902/
https://www.ncbi.nlm.nih.gov/pubmed/33583886
http://dx.doi.org/10.2169/internalmedicine.5813-20
_version_ 1783685314970124288
author Tawara, Junsuke
Uehara, Takanori
Sakao, Seiichiro
Igari, Hidetoshi
Taniguchi, Toshibumi
Kasai, Hajime
Takayanagi, Shin
Yahaba, Misuzu
Shimada, Ryo
Ikusaka, Masatomi
author_facet Tawara, Junsuke
Uehara, Takanori
Sakao, Seiichiro
Igari, Hidetoshi
Taniguchi, Toshibumi
Kasai, Hajime
Takayanagi, Shin
Yahaba, Misuzu
Shimada, Ryo
Ikusaka, Masatomi
author_sort Tawara, Junsuke
collection PubMed
description A 55-year-old Japanese man was hospitalized with the novel coronavirus disease 2019 (COVID-19). On the 14th day after the start of favipiravir administration, the patient developed a fever with a temperature of 38.1℃. His pulse rate also became elevated to 128 bpm, so relative bradycardia was not suspected. Since he was in good overall health and no concomitant symptoms and signs were apparent, we considered it to be drug fever due to favipiravir. After the completion of favipiravir treatment, the patient's temperature normalized within 24 hours. We herein report this case of drug fever caused by favipiravir.
format Online
Article
Text
id pubmed-8079902
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-80799022021-05-11 Drug Fever Due to Favipiravir Administration for the Treatment of a COVID-19 Patient Tawara, Junsuke Uehara, Takanori Sakao, Seiichiro Igari, Hidetoshi Taniguchi, Toshibumi Kasai, Hajime Takayanagi, Shin Yahaba, Misuzu Shimada, Ryo Ikusaka, Masatomi Intern Med Case Report A 55-year-old Japanese man was hospitalized with the novel coronavirus disease 2019 (COVID-19). On the 14th day after the start of favipiravir administration, the patient developed a fever with a temperature of 38.1℃. His pulse rate also became elevated to 128 bpm, so relative bradycardia was not suspected. Since he was in good overall health and no concomitant symptoms and signs were apparent, we considered it to be drug fever due to favipiravir. After the completion of favipiravir treatment, the patient's temperature normalized within 24 hours. We herein report this case of drug fever caused by favipiravir. The Japanese Society of Internal Medicine 2021-02-15 2021-04-01 /pmc/articles/PMC8079902/ /pubmed/33583886 http://dx.doi.org/10.2169/internalmedicine.5813-20 Text en Copyright © 2021 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Tawara, Junsuke
Uehara, Takanori
Sakao, Seiichiro
Igari, Hidetoshi
Taniguchi, Toshibumi
Kasai, Hajime
Takayanagi, Shin
Yahaba, Misuzu
Shimada, Ryo
Ikusaka, Masatomi
Drug Fever Due to Favipiravir Administration for the Treatment of a COVID-19 Patient
title Drug Fever Due to Favipiravir Administration for the Treatment of a COVID-19 Patient
title_full Drug Fever Due to Favipiravir Administration for the Treatment of a COVID-19 Patient
title_fullStr Drug Fever Due to Favipiravir Administration for the Treatment of a COVID-19 Patient
title_full_unstemmed Drug Fever Due to Favipiravir Administration for the Treatment of a COVID-19 Patient
title_short Drug Fever Due to Favipiravir Administration for the Treatment of a COVID-19 Patient
title_sort drug fever due to favipiravir administration for the treatment of a covid-19 patient
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079902/
https://www.ncbi.nlm.nih.gov/pubmed/33583886
http://dx.doi.org/10.2169/internalmedicine.5813-20
work_keys_str_mv AT tawarajunsuke drugfeverduetofavipiraviradministrationforthetreatmentofacovid19patient
AT ueharatakanori drugfeverduetofavipiraviradministrationforthetreatmentofacovid19patient
AT sakaoseiichiro drugfeverduetofavipiraviradministrationforthetreatmentofacovid19patient
AT igarihidetoshi drugfeverduetofavipiraviradministrationforthetreatmentofacovid19patient
AT taniguchitoshibumi drugfeverduetofavipiraviradministrationforthetreatmentofacovid19patient
AT kasaihajime drugfeverduetofavipiraviradministrationforthetreatmentofacovid19patient
AT takayanagishin drugfeverduetofavipiraviradministrationforthetreatmentofacovid19patient
AT yahabamisuzu drugfeverduetofavipiraviradministrationforthetreatmentofacovid19patient
AT shimadaryo drugfeverduetofavipiraviradministrationforthetreatmentofacovid19patient
AT ikusakamasatomi drugfeverduetofavipiraviradministrationforthetreatmentofacovid19patient

Ejemplares similares